Live Activities
Update on the Pathogenesis and Treatment of Parkinson's Disease and Related Disorders

March 4, 2012
La Paz, Bolivia

Course Description

The purpose of this course was to offer a forum for clinical and surgical discussion on Parkinson's disease and on a variety of movement disorder topics, including the presentation of current research and available treatments.

We selected a group of sessions with specific themes allowing participants to have an educational and comprehensive overview on subjects of broad interest to our community which allowed us to improve the quality of life of our patients.

Learning Objectives

At the conclusion of this activity, participants were able to accomplish the following:

  • Document the evolution of view of basal ganglia function.
  • Discuss recent advances in the genetics of movement disorders including new research perspectives with a specific focus on dominant parkinsonism.
  • Discuss new concepts of neurodegeneration.
  • Develop a strategy to implement a range of treatments available for the management of motor symptoms in the early and advanced Parkinson's disease.
  • Understand the frequency and relevance of non-motor symptoms in Parkinson's disease and their impact on quality of life.
  • Distinguish the major atypical parkinsonian disorders.
  • Identify the underpinnings and potential of using these disorders to understand and treat specific proteinopathies (i.e, alpha synucleinopathies and taupathies).
  • Define the clinical spectrum of cognitive and neuropsychiatric problems occurring in Parkinson's disease, Huntington's disease, and Tourette.
  • Recognize new developments in ablative lesions and DBS surgery for movement disorders.
  • Discuss indications and techniques to approach multiple targets.
  • Assess the relative advantages and disadvantages of ablative lesions versus DBS in Parkinson's disease.
  • Explain how basic science has helped to understand clinical manifestation, current management and future therapies of each disease.

Recommended Audience

This course was recommended for Movement Disorder specialists, general neurologists, general physicians, physicians in training, and students.